71 related articles for article (PubMed ID: 16212532)
1. Visualization and microscopic quantification of HCMV-peptide-specific cytotoxic T lymphocytes using tetramer binding.
Bissinger AL; Brugger J; Grigoleit GU; Gründemann C; Hebart H; Einsele H; Jahn G
Viral Immunol; 2005; 18(3):534-8. PubMed ID: 16212532
[TBL] [Abstract][Full Text] [Related]
2. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
Abu-Khader A; Krause S
Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609
[TBL] [Abstract][Full Text] [Related]
3. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
4. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
[TBL] [Abstract][Full Text] [Related]
5. [Preparation and characterization of HLA-A * 0201 monomer and tetramer loaded with HCMV antigenic peptide].
He XH; Xu LH; Liu Y; Cai XC; Zeng YY
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):382-8. PubMed ID: 15971610
[TBL] [Abstract][Full Text] [Related]
6. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.
Hebart H; Daginik S; Stevanovic S; Grigoleit U; Dobler A; Baur M; Rauser G; Sinzger C; Jahn G; Loeffler J; Kanz L; Rammensee HG; Einsele H
Blood; 2002 May; 99(10):3830-7. PubMed ID: 11986243
[TBL] [Abstract][Full Text] [Related]
7. Isolation and expansion of human cytomegalovirus- specific cytotoxic T lymphocytes using interferon-gamma secretion assay.
Bissinger AL; Rauser G; Hebart H; Frank F; Jahn G; Einsele H
Exp Hematol; 2002 Oct; 30(10):1178-84. PubMed ID: 12384149
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of HLA-A*0201 tetramer loaded with IE-1316-324 antigenic peptide of human cytomegalovirus.
Xu L; Zha Q; Sun H; Jia Q; Li F; He X
Cell Mol Immunol; 2006 Oct; 3(5):367-71. PubMed ID: 17092434
[TBL] [Abstract][Full Text] [Related]
9. Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.
Retière C; Prod'homme V; Imbert-Marcille BM; Bonneville M; Vié H; Hallet MM
J Virol; 2000 May; 74(9):3948-52. PubMed ID: 10756006
[TBL] [Abstract][Full Text] [Related]
10. Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice.
Lenfant F; Pizzato N; Liang S; Davrinche C; Le Bouteiller P; Horuzsko A
J Gen Virol; 2003 Feb; 84(Pt 2):307-317. PubMed ID: 12560562
[TBL] [Abstract][Full Text] [Related]
11. A modified peptide stimulation method for efficient amplification of cytomegalovirus (CMV)-specific CTLs.
Ruan GP; Ma L; Wen Q; Luo W; Zhou MQ; Wang XN
Cell Mol Immunol; 2008 Jun; 5(3):197-201. PubMed ID: 18582401
[TBL] [Abstract][Full Text] [Related]
12. Preparation and identification of HLA-A*1101 tetramer loading with human cytomegalovirus pp65 antigen peptide.
Li F; Xu L; Zha Q; Chi X; Jia Q; He X
Cell Mol Immunol; 2007 Apr; 4(2):141-6. PubMed ID: 17484809
[TBL] [Abstract][Full Text] [Related]
13. Identification of the HLA-A24 peptide epitope within cytomegalovirus protein pp65 recognized by CMV-specific cytotoxic T lymphocytes.
Masuoka M; Yoshimuta T; Hamada M; Okamoto M; Fumimori T; Honda J; Oizumi K; Itoh K
Viral Immunol; 2001; 14(4):369-77. PubMed ID: 11792066
[TBL] [Abstract][Full Text] [Related]
14. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus.
Solache A; Morgan CL; Dodi AI; Morte C; Scott I; Baboonian C; Zal B; Goldman J; Grundy JE; Madrigal JA
J Immunol; 1999 Nov; 163(10):5512-8. PubMed ID: 10553078
[TBL] [Abstract][Full Text] [Related]
15. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
16. [Quantification and phenotypic analysis of hCMV specific CTL in peripheral blood from HLA-A2+ donors].
Zha QB; He XH; Xu LH; Chi XY; Zeng YY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):247-51. PubMed ID: 16507265
[TBL] [Abstract][Full Text] [Related]
17. A simple and efficient method of generating HCMV pp65-specific T cells using overlapping peptides.
Hwang SU; Lee JH; Choi SY; Lee YT; Park SY; Lee HS; Jae JW; Jung NC; Wang Y; Lim DS
Acta Virol; 2020; 64(4):470-479. PubMed ID: 33151741
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs.
Gyulai Z; Endresz V; Burian K; Pincus S; Toldy J; Cox WI; Meric C; Plotkin S; Gönczöl E; Berencsi K
J Infect Dis; 2000 May; 181(5):1537-46. PubMed ID: 10823751
[TBL] [Abstract][Full Text] [Related]
19. Impaired killing of HCMV-infected retinal pigment epithelial cells by anti-pp65 CD8(+) cytotoxic T cells.
Allart S; Lulé J; Serres B; Jones T; Davignon JL; Malecaze F; Davrinche C
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):665-71. PubMed ID: 12556397
[TBL] [Abstract][Full Text] [Related]
20. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.
Tsai SL; Lee TH; Chien RN; Liao SK; Lin CL; Kuo GC; Liaw YF
J Immunol Methods; 2004 Feb; 285(1):71-87. PubMed ID: 14871536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
